Optimi Health (OPTI) Price & Analysis

Compare

39 Followers

OPTI Stock Chart & Stats

C$0.32

>-C$0.01(-2.38%)

At close: Jan 08 4:00 PM EST

C$0.32

>-C$0.01(-2.38%)

Day’s Range― - ―

52-Week RangeC$0.11 - C$0.42

Previous CloseN/A

Volume13.36K

Average Volume (3M)169.72K

Market Cap

C$28.07M

Enterprise ValueC$34.76M

Total Cash (Recent Filing)C$491.75K

Total Debt (Recent Filing)C$6.70M

Price to Earnings (P/E)―

Beta0.39

Next Earnings

May 27, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding96,776,920

10 Day Avg. Volume137,724

30 Day Avg. Volume169,715

Financial Highlights & Ratios

PEG Ratio0.24

Price to Book (P/B)5.70

Price to Sales (P/S)87.81

P/FCF Ratio-13.78

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Structural Industry OpportunityOptimi operates in the emerging psychedelics and functional mushroom wellness sectors, a structural growth market as regulation and clinical interest expand. This market positioning supports durable addressable demand for licensed producers and formulation specialists over the next 2-6 months and beyond.

Improving Cash Burn TrendOperating cash flow improved materially year-over-year, indicating management has reduced cash consumption. A sustained reduction in burn improves runway and reduces near-term financing pressure, increasing the likelihood the company can execute commercialization and regulatory steps without immediate capital raises.

Positive Equity BufferThe company retains positive shareholders' equity, providing a tangible balance-sheet cushion against operational losses. That equity base supports licensing, contract manufacturing and regulatory compliance activities that require capital before revenue ramps, giving time to execute the business plan.

Bears Say

Weak Revenue And Negative Gross ProfitA steep top-line decline and negative gross profit undermine scalability: the business currently fails to cover direct costs, making long-term margin sustainability unlikely without either higher sales volumes or materially lower unit costs. This is a structural barrier to approaching breakeven.

Ongoing Negative Cash GenerationPersistent negative operating and free cash flow means the company consumes capital to run operations and fund growth. Continued cash burn increases reliance on external financing, which can dilute shareholders or constrain investment in production capacity and regulatory compliance over the medium term.

Rising Leverage And Weakening Equity TrendMaterial debt growth and a debt-to-equity around 1.02 reduce financial flexibility for a loss-making company. Higher leverage increases interest and covenant risk, limiting the ability to fund regulatory approvals, capex, or scale production without further dilutive or expensive financing.

Optimi Health News

Optimi Health Advances Psilocybin Rollout for Treatment-Resistant Depression in Australia

Optimi Health ( ($TSE:OPTI) ) just unveiled an update. Optimi Health has begun early clinical rollout of its...

15d ago

Optimi Health Expands Australian Footprint With Psilocybin Export for TRD

Optimi Health ( ($TSE:OPTI) ) has shared an announcement. Optimi Health has completed the export of its GMP-manufactured...

22d ago

Optimi Health Expands MDMA-Assisted PTSD Treatments Across Australian Clinics

Optimi Health ( ($TSE:OPTI) ) has shared an update. Optimi Health has begun the first MDMA-assisted treatments of...

23d ago

Optimi Health Ships MDMA to Australia for PTSD Treatment Programs

Optimi Health ( ($TSE:OPTI) ) has issued an update. Optimi Health has completed its first MDMA export of...

1M ago

Optimi Health Begins 2026 Shipments of MDMA and Psilocybin Capsules to Australia

Optimi Health ( ($TSE:OPTI) ) has provided an update. Optimi Health has completed its first 2026 production cycle...

2M ago

Optimi Health Grants Equity Incentives and Launches New Investor Awareness Campaigns

An announcement from Optimi Health ( ($TSE:OPTI) ) is now available. Optimi Health has approved an equity incentive...

2M ago

Optimi Health to Court Institutional Investors at Sidoti Micro-Cap Conference

Optimi Health ( ($TSE:OPTI) ) has shared an announcement. Optimi Health Corp. will present at the Sidoti Micro-Cap...

2M ago

Optimi Health Adds Risk Management Veteran Jason Mosberian to Board

An update from Optimi Health ( ($TSE:OPTI) ) is now available. Optimi Health has appointed Jason Mosberian to...

3M ago

Optimi Health to Supply MDMA for Israeli PTSD Clinical Trial

Optimi Health ( ($TSE:OPTI) ) has issued an announcement. Optimi Health has been chosen to supply MDMA capsules...

4M ago

Optimi Health Achieves GMP Compliance and Enhances Market Liquidity

The latest update is out from Optimi Health ( ($TSE:OPTI) ). Optimi Health Corp. has successfully passed its...

5M ago

OPTI FAQ

What was Optimi Health’s price range in the past 12 months?

Optimi Health lowest stock price was C$0.10 and its highest was C$0.42 in the past 12 months.

What is Optimi Health’s market cap?

Optimi Health’s market cap is C$28.07M.

When is Optimi Health’s upcoming earnings report date?

Optimi Health’s upcoming earnings report date is May 27, 2026 which is in 75 days.

How were Optimi Health’s earnings last quarter?

Currently, no data Available

Is Optimi Health overvalued?

According to Wall Street analysts Optimi Health’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Optimi Health pay dividends?

Optimi Health does not currently pay dividends.

What is Optimi Health’s EPS estimate?

Optimi Health’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Optimi Health have?

Optimi Health has 96,776,920 shares outstanding.

What happened to Optimi Health’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Optimi Health?

Currently, no hedge funds are holding shares in TSE:OPTI

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Optimi Health

Optimi Health Corp. develops an integrated functional mushroom brand that focuses on the health and wellness food markets in Canada. The company also focuses on the cultivation, extraction, processing, and distribution of strains of functional mushroom. It offers a range of fungi varieties, which include Lions Mane, Reishi, Turkey Tail, Chaga, and Cordyceps. The company was formerly known as 1251418 BC Ltd. and changed its name to Optimi Health Corp. in August 2020. Optimi Health Corp. was incorporated in 2020 and is headquartered in Vancouver, Canada.